In both cancer and developmental contexts, phenotypes caused by RB dysfunction could be rescued by inhibiting KDM5A, leading to the hypothesis that at least part of the functional link between RB and KDM5A may be based on antagonizing roles (Benevolenskaya et al., 2005; Lin et al., 2011). This evidence concerns the gene RB1 and cancer.